NPC Blog
Update on the Phase IIb Clinical Trial Data
Posted on Oct 3rd, 2008 by David Isserman
For the past week, we have fielded several phone calls and emails asking us about the status of our clinical data for our Phase IIb study in treating Adrenomyeloneuropathy (AMN). While we are working diligently to get this information compiled, analyzed, and published as quickly as possible, it has taken a little longer than expected due to a lag in data collection from the last several patients in the Trial.
We understand how anxious and excited you are to learn more about the results of this trial. We are too! Please bear with us as we continue to process the data. We expect to have it available towards the end of October.
1 Comment
RSS feed for comments on this post.
TrackBack URL
Leave a Comment

















Dear Madame,
Dear Sir,
One of my patients has the disease
adrenomyeloneuropathy
I am looking forward to hear from you, your clinical results
Yours faithfully,
dr. E. de Winter
neurosurgeon
Comment by dr. E. De Winter — October 29, 2008 @ 9:38 am